logo
Select company
Select metric
2.22Cash Ratio
VS
Market
83
Sector
67
Industry
55
History
8
$ 8.76Close
$ 3.99 - $ 9.88 52-Week Range
Ticker Information

Ticker

FENC

Company Name

FENNEC PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FENNEC PHARMACEUTICALS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FENC - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 18.7M2.22$ 8.41M
3/31/2025$ 22.68M2.71$ 8.37M
12/31/2024$ 26.63M3.85$ 6.92M
9/30/2024$ 40.32M5.42$ 7.43M
6/30/2024$ 43.05M5.56$ 7.75M
3/31/2024$ 51.18M5.2$ 9.84M
12/31/2023$ 13.27M1.76$ 7.55M
9/30/2023$ 12.4M3.17$ 3.91M
6/30/2023$ 14.96M3.96$ 3.78M
3/31/2023$ 18.39M4.57$ 4.02M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FENNEC PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash Ratio stands at 11.5.
  • Over the past 5 years, FENNEC PHARMACEUTICALS INC's average Cash Ratio has been 7.9.
  • The median Cash Ratio for FENNEC PHARMACEUTICALS INC during this period was 5.31
  • FENNEC PHARMACEUTICALS INC reached its highest Cash Ratio over the past 5 years at 32.19.
  • The lowest Cash Ratio recorded by FENNEC PHARMACEUTICALS INC in the same timeframe 1.76

FENNEC PHARMACEUTICALS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
CCCC : C4 THERAPEUTICS INC 1.84VYGR : VOYAGER THERAPEUTICS INC 1.12EDIT : EDITAS MEDICINE INC 2.1OABI : OMNIAB INC 1.49FHTX : FOGHORN THERAPEUTICS INC 0.97SCPH : SCPHARMACEUTICALS INC 2STXS : STEREOTAXIS INC 0.34LCTX : LINEAGE CELL THERAPEUTICS INC 3.93MGX : METAGENOMI INC 0.96MXCT : MAXCYTE INC 1.32

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for FENNEC PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 33.17M ] / LiabilitesC [ $ 2.88M ]
(=) Cash Ratio [ 11.5 ]

FENC - Cash Ratio, Last 5 years

1.76

Minimum

Dec 31, 2023

32.19

Maximum

Jun 30, 2021

7.9

Average

5.31

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63